Clal Insurance’s Gilead Sciences GILD Stock Holding History

Clal Insurance’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,000	Closed	-$525K	–	133
2023 Q3	$525K	Hold	7,000	–	–	0.01%	106
2023 Q2	$539K	Sell	7,000 -3,000	-30%	-$239K	0.01%	120
2023 Q1	$830K	Buy	+10,000	New	+$828K	0.01%	118
2015 Q2	–	Sell	-110,820	Closed	-$10.9M	–	112
2015 Q1	$10.9M	Buy	+110,820	New	+$11.3M	0.25%	59

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Clal Insurance's GILD Position: Q4 2023 in Review

Clal Insurance sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 7,000 shares — an estimated $525K sold.

Clal Insurance first reported a position in GILD in Q1 2015 and held it in 4 quarters. The position peaked at $10.9M in Q1 2015. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

Clal Insurance reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
Clal Insurance sold 7,000 Gilead Sciences shares in Q4 2023, an estimated $525K.
Clal Insurance first reported a position in Gilead Sciences in Q1 2015 and held it in 4 quarters.
Clal Insurance's Gilead Sciences position peaked at $10.9M in Q1 2015.
1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Clal Insurance's 13F filing for Q4 2023, filed 14 Feb 2024.